SBC / revenue moved 841 bp lower
SBC / revenue changed -841 basis points from the comparable as-filed period.
23.04%→14.63%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →U financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Receivables / revenue moved 926 bp lower
Receivables / revenue changed -926 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
135.29%→126.03%2 prior comparisons
Capital expenditure decreased 43.2%
Capital expenditure changed -43.2% from the comparable as-filed period.
$6.4M→$3.7M3 prior comparisons
Free-cash-flow margin moved 823 bp higher
Free-cash-flow margin changed +823 basis points from the comparable as-filed period.
28.72%→36.96%2 prior comparisons
Operating cash-flow margin moved 744 bp higher
Operating cash-flow margin changed +744 basis points from the comparable as-filed period.
30.18%→37.63%2 prior comparisons
Stock-based compensation decreased 21.3%
Stock-based compensation changed -21.3% from the comparable as-filed period.
$101.6M→$79.9M2 prior comparisons
Current ratio decreased 25.7%
Current ratio changed -25.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
2.73→2.034 prior comparisons
Capex / revenue moved 79 bp lower
Capex / revenue changed -79 basis points from the comparable as-filed period.
1.46%→0.67%2 prior comparisons
R&D / revenue moved 221 bp higher
R&D / revenue changed +221 basis points from the comparable as-filed period.
48.72%→50.92%2 prior comparisons
Shares outstanding increased 4.2%
Shares outstanding changed +4.2% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
422,517,888→440,088,9338 prior comparisons
Working capital increased 5.7%
Working capital changed +5.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.5B→$1.6B4 prior comparisons
Total assets decreased 0.8%
Total assets changed -0.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$6.7B→$6.7B4 prior comparisons
Cost of revenue decreased 2.2%
Cost of revenue changed -2.2% from the comparable as-filed period.
$114.2M→$111.7M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.